In accordance, two recent studies linked low CES2 expression in cancer cell lines to DAG (and lysoPC) accumulation, which could be reversed upon CES2 overexpression, albeit these studies show a divergent impact of CES2 expression levels and the overall survival of cancer patients [21,22]. This evidence concerns the gene CES2 and cancer.